DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02950883 (ClinicalTrials.gov)	August 2016	27/10/2016	Saline Hypertonic in Preschoolers + CT	Saline Hypertonic in Preschoolers With Cystic Fibrosis and Lung Structure as Measured by Computed Tomography (CT)	Cystic Fibrosis	Drug: Active Treatment Group 7% Hypertonic Saline;Drug: Control Group 0.9% Isotonic Saline	University of Washington, the Collaborative Health Studies Coordinating Center	Cystic Fibrosis Foundation	Active, not recruiting	3 Years	5 Years	All	116	Phase 2;Phase 3	United States;Australia;Belgium;Canada;Denmark;France;Italy;Netherlands;Spain

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

August 2016

27/10/2016

Saline Hypertonic in Preschoolers + CT

Saline Hypertonic in Preschoolers With Cystic Fibrosis and Lung Structure as Measured by Computed Tomography (CT)

Cystic Fibrosis

Drug: Active Treatment Group 7% Hypertonic Saline;Drug: Control Group 0.9% Isotonic Saline

University of Washington, the Collaborative Health Studies Coordinating Center

Cystic Fibrosis Foundation

Active, not recruiting

3 Years

5 Years

All

116

Phase 2;Phase 3

United States;Australia;Belgium;Canada;Denmark;France;Italy;Netherlands;Spain